Array BioPharma Inc. (ARRY)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
6.30+0.01 (+0.24%)
As of 3:00 PM EDT. Market open.
People also watch:
ARQLEXELCLDXRIGLARIA
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open6.36
Prev Close6.28
Bid6.26 x 1100
Ask6.27 x 6800
Day's Range6.05 - 6.50
52wk Range2.38 - 7.27
1y Target EstN/A
Market Cap912.92M
P/E Ratio (ttm)-9.68
Beta1.14
Volume10,689,563
Avg Vol (3m)4,739,700
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Investopedia21 hours ago

    Array BioPharma Reports Positive Results (ARRY)

    Positive top-line data is paving the way for the company to apply for global regulatory approvals.

  • Why Wells Fargo, Select Comfort, Array Biopharma, American Express, and More Are Trending
    Insider Monkeyyesterday

    Why Wells Fargo, Select Comfort, Array Biopharma, American Express, and More Are Trending

    With this month’s two major catalysts now over, the markets are relatively quiet, as all three major indexes are slightly in the green at the start of this morning’s trading. In this article, we’ll find out why investors are buzzing about two big Warren Buffett favorites, along with three other companies. Those stocks are Wells Fargo […]

  • PR Newswire2 days ago

    Array BioPharma Announces Pricing of Public Offering of Common Stock

    Array also granted the underwriters a 30-day option to purchase up to 2,760,000 additional shares of common stock. J.P. Morgan Securities LLC and Cowen and Company, LLC are acting as joint book-running managers for the offering.  Stifel and Wells Fargo Securities, LLC are acting as lead managers and SunTrust Robinson Humphrey, Inc. is acting as co-manager. Copies of the preliminary prospectus supplement and the accompanying prospectus, and when available, copies of the final prospectus supplement and the accompanying prospectus relating to these securities may also be obtained by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 866-803-9204, or Cowen and Company, LLC, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, New York, 11717, Attn: Prospectus Department, telephone: 631-274-2806.